ZIOPHARM ONCOLOGY INC's ticker is ZIOP and the CUSIP is 98973P101. A total of 126 filers reported holding ZIOPHARM ONCOLOGY INC in Q2 2022. The put-call ratio across all filers is 0.02 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $6,026 | -99.5% | 45,720 | -98.1% | 0.00% | – |
| Q2 2023 | $1,255,997 | -20.8% | 2,462,740 | -2.2% | 0.00% | – |
| Q1 2023 | $1,586,000 | +96962.4% | 2,517,426 | +0.0% | 0.00% | – |
| Q4 2022 | $1,634 | -100.0% | 2,516,585 | -0.3% | 0.00% | -100.0% |
| Q3 2022 | $4,344,000 | -17.0% | 2,525,243 | -40.1% | 0.00% | 0.0% |
| Q2 2022 | $5,231,000 | +144.4% | 4,218,482 | +28.6% | 0.00% | – |
| Q1 2022 | $2,140,000 | -46.4% | 3,280,446 | -10.4% | 0.00% | – |
| Q4 2021 | $3,992,000 | -40.3% | 3,663,225 | -0.2% | 0.00% | -100.0% |
| Q3 2021 | $6,685,000 | -47.6% | 3,672,398 | -24.0% | 0.00% | -50.0% |
| Q2 2021 | $12,763,000 | -32.6% | 4,834,536 | -8.1% | 0.00% | -33.3% |
| Q1 2021 | $18,945,000 | +187.6% | 5,262,386 | +101.3% | 0.00% | +200.0% |
| Q4 2020 | $6,587,000 | +40.5% | 2,614,044 | +43.3% | 0.00% | 0.0% |
| Q3 2020 | $4,688,000 | -0.6% | 1,824,198 | +26.9% | 0.00% | 0.0% |
| Q2 2020 | $4,714,000 | +230.6% | 1,437,394 | +147.0% | 0.00% | – |
| Q1 2020 | $1,426,000 | +26.2% | 581,942 | +143.0% | 0.00% | – |
| Q4 2019 | $1,130,000 | +402.2% | 239,487 | +354.4% | 0.00% | – |
| Q3 2019 | $225,000 | -11.1% | 52,703 | +19.3% | 0.00% | – |
| Q2 2019 | $253,000 | +104.0% | 44,169 | +37.3% | 0.00% | – |
| Q1 2019 | $124,000 | +96.8% | 32,179 | -4.5% | 0.00% | – |
| Q4 2018 | $63,000 | -35.7% | 33,687 | +10.2% | 0.00% | – |
| Q3 2018 | $98,000 | +21.0% | 30,556 | +14.0% | 0.00% | – |
| Q2 2018 | $81,000 | -49.1% | 26,800 | -33.9% | 0.00% | – |
| Q1 2018 | $159,000 | +35.9% | 40,533 | +42.6% | 0.00% | – |
| Q4 2017 | $117,000 | +11600.0% | 28,427 | +20649.6% | 0.00% | – |
| Q3 2017 | $1,000 | 0.0% | 137 | 0.0% | 0.00% | – |
| Q2 2017 | $1,000 | -99.8% | 137 | -99.8% | 0.00% | – |
| Q1 2017 | $495,000 | -54.2% | 78,138 | -61.3% | 0.00% | – |
| Q4 2016 | $1,080,000 | – | 201,858 | +380764.2% | 0.00% | – |
| Q3 2016 | $0 | -100.0% | 53 | -90.6% | 0.00% | – |
| Q2 2016 | $3,000 | – | 562 | +960.4% | 0.00% | – |
| Q1 2016 | $0 | -100.0% | 53 | -87.7% | 0.00% | – |
| Q4 2015 | $3,000 | -97.9% | 432 | -98.8% | 0.00% | – |
| Q3 2013 | $145,000 | -21.6% | 36,763 | -58.1% | 0.00% | – |
| Q2 2013 | $185,000 | – | 87,833 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| DISCOVERY CAPITAL MANAGEMENT, LLC / CT | 14,013,093 | $9,142,000 | 0.78% |
| MSD Partners, L.P. | 15,151,516 | $9,885,000 | 0.54% |
| MSD Partners, L.P. | 7,575,758 | $4,942,000 | 0.27% |
| CHIRON CAPITAL MANAGEMENT, LLC | 144,960 | $95,000 | 0.06% |
| MAGNOLIA CAPITAL ADVISORS LLC | 185,456 | $121,000 | 0.05% |
| Allred Capital Management, LLC | 128,000 | $83,000 | 0.04% |
| Virtus ETF Advisers LLC | 131,413 | $86,000 | 0.04% |
| GSA CAPITAL PARTNERS LLP | 232,438 | $152,000 | 0.02% |
| ACT WEALTH MANAGEMENT, LLC | 37,071 | $24,000 | 0.01% |
| Pathway Financial Advisors LLC | 30,000 | $20,000 | 0.01% |